Revive Therapeutics (TSX VENTURE:RVV) (OTCQB:RVVTF)
Advances Research Program of #Cannabinoid-Based Drug Delivery Technology for
the Medical Marijuana and Pharmaceutical Markets
TORONTO, ONTARIO - September 12, 2017
(Investorideas.com Newswire) Revive Therapeutics Ltd. ("Revive" or
the "Company") (TSX VENTURE:RVV) (OTCQB:RVVTF), a company focused on
the research, development and commercialization of novel treatments for serious
and unmet medical needs, today announced the advancement of the research
program with the University of Wisconsin-Madison to evaluate a novel drug
delivery technology with a focus on cannabinoids for the potential to treat
various diseases, such as pain and inflammation for the medical marijuana and
pharmaceutical markets for Canada and the United States. The Company intends to
develop novel therapies and partner with licensed medical marijuana producers
and partner with pharmaceutical companies requiring a unique and validated drug
delivery technology for their development and commercial therapeutic pipelines.
Read this release in full at http://www.investorideas.com/news/2017/marijuana/09121RVV.asp
Marijuana /
Hemp Stocks
Like Marijuana Stocks? View our Marijuana / Hemp
Stocks Directory
Join our Group on Linkedin - Marijuana / Hemp
Stocks - News and Trends in Green Investing
Watch the 420 Cannabis Investor video
This
news is published on the Investorideas.com Newswire - a global digital news
source for investors and business leaders
Disclaimer/Disclosure: Investorideas.com is a digital publisher of
third party sourced news, articles and equity research as well as creates
original content, including video, interviews and articles. Original content
created by investorideas is protected by copyright laws other than syndication
rights. Our site does not make recommendations for purchases or sale of stocks,
services or products. Nothing on our sites should be construed as an offer or
solicitation to buy or sell products or securities. All investment involves risk
and possible loss of investment. This site is currently compensated for news
publication and distribution, social media and marketing, content creation and
more. Contact each company directly regarding content and press release
questions. Disclosure is posted for each compensated news release, content
published /created if required but otherwise the news was not compensated for
and was published for the sole interest of our readers and followers. More
disclaimer info: http://www.investorideas.com/About/Disclaimer.asp
Additional
info regarding BC Residents and global Investors: Effective September 15 2008 -
all BC investors should review all OTC and Pink sheet listed companies for
adherence in new disclosure filings and filing appropriate documents with
Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894.
Global investors must adhere to regulations of each country.
No comments:
Post a Comment